The recombinant antibody market is quickly expanding as researchers look for monoclonal antibody alternatives. These recombinant antibodies have inherent advantages and disadvantages. Join Rockland's Product Manager, Todd Giardiello, and our Chief Science Officer, Dr. Carl Ascoli as we discuss recombinant antibodies.
Contents:
(00:00) Intro
(00:43) What are recombinant antibodies?
(01:12) How are recombinant antibodies produced?
(02:10) How does the manufacturing process of recombinant antibodies differ from traditional monoclonal antibodies?
(03:05) How do recombinant antibodies compare to a more traditional murine-derived monoclonal antibodies?
(04:04) How does that differ from recombinant monoclonal antibodies? (reference previous question)
(04:47) What are some of the key benefits to using recombinant antibodies?
(06:56) What are some limitations to recombinant antibody production and performance?
(08:12) Are recombinant antibodies better suited for any immunoassay applications, more so than polyclonal or monoclonal antibodies?
(09:00) Do you expect market trends to continue or do you expect that the benefits discussed today will sway immunoassay manufacturers in their direction?
(10:08) Closing Remarks
► Learn more about Rockland's custom antibody services
rockland-inc.com/custom-antib...
► Don't forget to follow us on social!
/ rockland-immunochemica...
/ rockland_inc
/ rockland_inc
--------------------------------------------------------------------------------------------------------------------
#Recombinantantibodies #monoclonalantibodies #antibodies #monoclonal #recombinant